11 reports of this reaction
1.9% of all HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE reports
#11 most reported adverse reaction
URINARY TRACT INFECTION is the #11 most commonly reported adverse reaction for HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE, manufactured by Legacy Pharma USA Inc.. There are 11 FDA adverse event reports linking HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE to URINARY TRACT INFECTION. This represents approximately 1.9% of all 571 adverse event reports for this drug.
Patients taking HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE who experience urinary tract infection should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
URINARY TRACT INFECTION is a less commonly reported adverse event for HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to urinary tract infection, the following adverse reactions have been reported for HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE:
The following drugs have also been linked to urinary tract infection in FDA adverse event reports:
URINARY TRACT INFECTION has been reported as an adverse event in 11 FDA reports for HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
URINARY TRACT INFECTION accounts for approximately 1.9% of all adverse event reports for HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE, making it a notable side effect.
If you experience urinary tract infection while taking HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.